News
🌏 NMPA Page 11Latest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 121–132 of 248 articles
ImmunityBio Faces Securities Fraud Lawsuit Over Anktiva Off-Label Promotion After FDA Warning Letter
Oncology - Bladder Cancer · 3 min
Sophie MartinChinaBio Partnering Forum 2026: Key Takeaways and Highlights
biotech · 6 min
Sophie MartinChinaBio Partnering Forum: Biotech Deals & APAC Innovation
biotech · 8 min
Sophie MartinInsilico Medicine's Rentosertib Inhalation Solution Receives IND Clearance for First AI-Driven Direct-to-Lung Clinical Trial
2 min
Sophie MartinThailand Emerges as ASEAN Medical Device Gateway as Market Set to Reach $18.6B by 2029
2 min
Sophie MartinYangtze River Pharmaceutical Group Quadruples International Revenue in 2025 Global Expansion
2 min
Sophie MartinSoleno Therapeutics Faces Securities Fraud Lawsuit Over Alleged Sham Phase 3 Clinical Trials
Unknown · 4 min
Sophie MartinNewleos Begins Phase 1b Trial of NTX-2001 for Alcohol Use Disorder Treatment
2 min
Sophie MartinCitius Oncology Ships First LYMPHIR International Order to Europe, Expanding Global Cancer Treatment Access
2 min
Sophie MartinEirGenix Expands Japan Biosimilar Strategy at CPHI Japan 2026 Amid Regulatory Support
2 min
Sophie MartinChinaBio Partnering Forum: Biotech Deals & Investment Insights
biotech · 8 min
Sophie MartinTrialClinIQ Secures $150K Investment from Caduceus Capital to Transform Clinical Trial Recruitment with AI Technology
2 min
Sophie MartinPopular topics
- Drug Approvals 1,138 articles
- Clinical Trials 652 articles
- Regulatory Updates 695 articles
- Press Releases 443 articles
- Oncology 456 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 143 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways